Thu, 17th Dec 2015 10:08
LONDON (Alliance News) - Advanced Oncotherapy PLC Thursday said Non-Executive Director Michael Bradfield bought 750,000 shares at a price of 5.5 pence per share Wednesday.
Following this transaction, Bradfield now holds 122.8 million shares, which represents 8.66% of the issued share capital.
Shares in the medical technology company were up 4.2% at 5.60p Thursday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Provides update in relation to financing discussions and fin...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Regarding its recapitalisation plan, company works alongside...
Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Continues to work on its recapitalisation plan with an unnam...
